Retrieve available abstracts of 11 articles: HTML format
Single Articles
August 2025
HUANG Y, Lin H, Shi J, Chen Y, et al Serum metabolic patterns reveal the diagnostic and prognostic role of alanine
abnormality in ocular adnexal lymphoma.
Proc Natl Acad Sci U S A. 2025;122:e2506345122. PubMedAbstract available
June 2025
ZHANG N, Seo JW, Robinson E, Rivera-Rodriguez A, et al Development of an in situ CAR-T cell protocol through optical and PSMA-targeted
PET imaging.
Proc Natl Acad Sci U S A. 2025;122:e2504950122. PubMedAbstract available
April 2025
TILI E, Commisso TL, Balatti V, Michaille JJ, et al miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas.
Proc Natl Acad Sci U S A. 2025;122:e2422615122. PubMedAbstract available
December 2024
CERIBELLI M, Tosto FA, Zhang X, Melani CJ, et al Multi-Component, Time-Course screening to develop combination cancer therapies
based on synergistic toxicity.
Proc Natl Acad Sci U S A. 2024;121:e2413372121. PubMedAbstract available
July 2024
ZHONG X, Moresco JJ, SoRelle JA, Song R, et al Disruption of the ZFP574-THAP12 complex suppresses B cell malignancies in mice.
Proc Natl Acad Sci U S A. 2024;121:e2409232121. PubMedAbstract available
April 2024
LI MY, Chong LC, Duns G, Lytle A, et al TRAF3 loss-of-function reveals the noncanonical NF-kappaB pathway as a therapeutic
target in diffuse large B cell lymphoma.
Proc Natl Acad Sci U S A. 2024;121:e2320421121. PubMedAbstract available
MAROUI MA, Odongo GA, Mundo L, Manara F, et al Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell
infection.
Proc Natl Acad Sci U S A. 2024;121:e2314426121. PubMedAbstract available
KRISTENSON L, Badami C, Ljungberg A, Islamagic E, et al Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell
cytotoxicity.
Proc Natl Acad Sci U S A. 2024;121:e2316447121. PubMedAbstract available
March 2024
MA J, Al Moussawi K, Lou H, Chan HF, et al Deficiency of factor-inhibiting HIF creates a tumor-promoting immune
microenvironment.
Proc Natl Acad Sci U S A. 2024;121:e2309957121. PubMedAbstract available
January 2024
Correction for Scuoppo et al., Repurposing dasatinib for diffuse large B cell
lymphoma.
Proc Natl Acad Sci U S A. 2024;121:e2321988121. PubMed
December 2023
JUILLAND M, Alouche N, Ubezzi I, Gonzalez M, et al Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and
lymphoma dissemination.
Proc Natl Acad Sci U S A. 2023;120:e2301155120. PubMedAbstract available